XTL Biopharmaceuticals Ltd ADR (XTLB)

Currency in USD
1.450
-0.260(-15.20%)
Closed·
After Hours
1.430-0.020(-1.38%)
·
XTLB Scorecard
Full Analysis
Suffers from weak gross profit margins
XTLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.4001.590
52 wk Range
0.8602.973
Key Statistics
Prev. Close
1.71
Open
1.59
Day's Range
1.4-1.59
52 wk Range
0.86-2.973
Volume
14.7K
Average Volume (3m)
37.25K
1-Year Change
-42.46%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XTLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

XTL Biopharmaceuticals Ltd ADR Company Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren’s syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

Compare XTLB to Peers and Sector

Metrics to compare
XTLB
Peers
Sector
Relationship
P/E Ratio
−12.9x−1.8x−0.5x
PEG Ratio
−1.56−0.030.00
Price/Book
2.4x2.3x2.6x
Price / LTM Sales
29.4x7.9x3.3x
Upside (Analyst Target)
-433.3%42.8%
Fair Value Upside
Unlock27.5%6.5%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
405.00K / --
EPS Revisions
Last 90 days

XTLB Income Statement

People Also Watch

16.75
SRPT
-2.05%
0.532
WINT
-8.59%
2.69
INMB
-5.95%
8.2100
CYCC
-16.31%
0.98
KLTO
-2.00%

FAQ

What Stock Exchange Does XTL Biopharma Trade On?

XTL Biopharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for XTL Biopharma?

The stock symbol for XTL Biopharma is "XTLB."

What Is the XTL Biopharma Market Cap?

As of today, XTL Biopharma market cap is 13.29M.

What Is XTL Biopharma's Earnings Per Share (TTM)?

The XTL Biopharma EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is XTLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has XTL Biopharma Stock Split?

XTL Biopharma has split 2 times.

How Many Employees Does XTL Biopharma Have?

XTL Biopharma has 10 employees.

What is the current trading status of XTL Biopharma (XTLB)?

As of 06 Aug 2025, XTL Biopharma (XTLB) is trading at a price of 1.45, with a previous close of 1.71. The stock has fluctuated within a day range of 1.40 to 1.59, while its 52-week range spans from 0.86 to 2.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.